Feedback / Questions
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Adcetris (brentuximab vedotin) - Takeda, Pfizer
http://www.ncbi.nlm.nih.gov/pubmed/36164029
Sep 29, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next